0000899243-20-033739.txt : 20201214
0000899243-20-033739.hdr.sgml : 20201214
20201214162059
ACCESSION NUMBER: 0000899243-20-033739
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: IVERS-READ GILLIAN C
CENTRAL INDEX KEY: 0001268304
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 201386399
MAIL ADDRESS:
STREET 1: C/O PHARMION CORPORATION
STREET 2: 2525 28TH STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-10
0
0001466301
Clovis Oncology, Inc.
CLVS
0001268304
IVERS-READ GILLIAN C
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
0
1
0
0
See Remarks
Common Stock
2020-12-10
4
M
0
68965
3.28
A
284487
D
Common Stock
2020-12-10
4
F
0
52447
4.81
D
232040
D
Employee Stock Option (right to buy)
3.28
2020-12-10
4
M
0
68965
0.00
D
2021-03-08
Common Stock
68965
0
D
The option vested as to 25% of the shares on March 8, 2012, and the remainder vested in substantially equal installments over the 36 months immediately following such date.
Executive Vice President of Technical Operations and Chief Regulatory Officer
/s/ Gillian C. Ivers-Read
2020-12-13